Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud.

These high capital-intensity, asset-heavy companies offer a proven hedge against 'Magnificent Seven' volatility "Anti-AI" stocks are a contrarian bet that the market's tech-fueled rally will be ...

BioMedWire Editorial Coverage: The ability to accurately detect drug and alcohol intoxication has long been a persistent challenge across industries, from law ...

If you are a community college student building Python skills alongside microcontrollers and robotics projects, the PCEP-30-02 certification is your fastest, most credible way to validate those skills ...

Complete NYT Spelling Bee Answers Today for May 8, 2026 including pangrams, hints, and full solution breakdown for players.

A total of 28 companies joined The Crunchbase Unicorn Board in April, with robotics startups and frontier labs leading by ...

Chris Gibson built the pioneering AI biotech Recursion Pharmaceuticals on a foundation of bold promises. But after more than ...

Natural Resource Partners LP (NRP) is expected to report $1.30 for 1Q. Northwest Natural Holding Co (NWN) is expected to report $2.40 for 1Q. Owens Corning (OC) is expected to report $0.98 for 1Q.

Enterprise AI systems can be corrupted through data poisoned by accident, adversaries, or bad hygiene. Most organizations ...

With "Project Hail Mary" dominating the box office, author Andy Weir is steering fans toward Blake Crouch’s mind-bending sci-fi thriller "Recursion." Weir has repeatedly named it his top ...

Detailed price information for Twist Bioscience Corp (TWST-Q) from The Globe and Mail including charting and trades.